CDP supporting the growth of Bormioli Pharma, leader in hi-tech packaging for the pharmaceutical industry

CDP supporting the growth of Bormioli Pharma, leader in hi-tech packaging for the pharmaceutical industry

30 million euros for Emilian group growth in Italy and abroad

The history

From traditional jars for preserving food to hi-tech glass for pharmaceuticals. Bormioli Pharma was established through the spin-off of a company branch of the Bormioli Rocco SpA group, a centuries-old Parma company founded in 1825 by the Bormioli family and specialised in glass containers.

2017 was a real turning point for the company. The historic glass factory in Parma was returned to Italian control after being managed for six years by the London fund Vision Capital and the Pharma division, acquired by the private equity fund Triton, became independent.

The development of a Made in Italy brand of excellence

On the arrival of a young CEO, engineer Andrea Lodetti, with his industrial career background, the company made a leap in quality. In a little over two years, Bormioli Pharma has grown from 900 to 1,200 employees, five to eight plants and from just over 200 to over 235 million euros in turnover, with 60% from exports, working in over 120 countries across the world. The company has become a leader in the production of plastic and glass containers and packaging for the pharmaceutical, biopharmaceutical and nutraceutical market, as well as packaging accessories and closures.

Recognised worldwide for the level of quality and innovation of its products, the group has transformed itself from a packaging supplier into an partner of excellence for the global pharmaceutical industry.

The role of Cassa Depositi e Prestiti

To further support the growth of Bormioli Pharma in Italy and abroad, Cassa Depositi e Prestiti, together with Crédit Agricole Italia, have granted a loan of 30 million euros.
The financing, with Cassa Depositi e Prestiti as Arranger and Crédit Agricole Italia as Arranger and pool Bank agent, also provides for the issue of an ordinary guarantee by SACE for a total of 10 million euros.

With this transaction, intended to support Bormioli Pharma's investment plans, CDP has confirmed its commitment to support the international market growth plans of an important Italian industrial company which, despite the difficult current situation, continues to invest to strengthen its competitiveness in Italy and on international markets, generating value, jobs and new business opportunities.

With this transaction, Cassa Depositi e Prestiti is contributing to the achievement of sustainable development goal 8 of the UN 2030 Agenda.